WO2005107818A3 - Nanoparticles and their use for multifunctional bioimaging - Google Patents
Nanoparticles and their use for multifunctional bioimaging Download PDFInfo
- Publication number
- WO2005107818A3 WO2005107818A3 PCT/US2005/015266 US2005015266W WO2005107818A3 WO 2005107818 A3 WO2005107818 A3 WO 2005107818A3 US 2005015266 W US2005015266 W US 2005015266W WO 2005107818 A3 WO2005107818 A3 WO 2005107818A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bioimaging
- multifunctional
- nanoparticles
- vivo
- multifaceted
- Prior art date
Links
- 239000002105 nanoparticle Substances 0.000 title abstract 2
- 238000001727 in vivo Methods 0.000 abstract 2
- 210000004556 brain Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000002872 contrast media Substances 0.000 abstract 1
- 238000002059 diagnostic imaging Methods 0.000 abstract 1
- 238000003384 imaging method Methods 0.000 abstract 1
- 238000001361 intraarterial administration Methods 0.000 abstract 1
- 238000013507 mapping Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 210000000130 stem cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
- A61K49/0067—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle quantum dots, fluorescent nanocrystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/183—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an inorganic material or being composed of an inorganic material entrapping the MRI-active nucleus, e.g. silica core doped with a MRI-active nucleus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
- Y10S977/774—Exhibiting three-dimensional carrier confinement, e.g. quantum dots
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/590,590 US8128908B2 (en) | 2004-04-30 | 2005-05-02 | Nanoparticles and their use for multifunctional bioimaging |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56733004P | 2004-04-30 | 2004-04-30 | |
US60/567,330 | 2004-04-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005107818A2 WO2005107818A2 (en) | 2005-11-17 |
WO2005107818A3 true WO2005107818A3 (en) | 2007-08-23 |
Family
ID=35115932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/015266 WO2005107818A2 (en) | 2004-04-30 | 2005-05-02 | Nanoparticles and their use for multifunctional bioimaging |
Country Status (2)
Country | Link |
---|---|
US (1) | US8128908B2 (en) |
WO (1) | WO2005107818A2 (en) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2869803B1 (en) * | 2004-05-10 | 2006-07-28 | Nanobiotix Sarl | ACTIVE PARTICLES, PREPARATION AND USES |
US20080118941A1 (en) * | 2004-09-02 | 2008-05-22 | The Regents Of The University Of California | Signal Peptide-Semiconductor Nanocrystal Conjugates |
EP1827508B1 (en) * | 2004-12-17 | 2009-08-19 | Koninklijke Philips Electronics N.V. | Targeting agents for molecular imaging |
US20070098642A1 (en) * | 2005-11-02 | 2007-05-03 | General Electric Company | Nanoparticle-based imaging agents for X-ray/computed tomography |
DE102005053618A1 (en) * | 2005-11-10 | 2007-05-16 | Merck Patent Gmbh | Nanoscale particles as contrast agent for magnetic resonance imaging |
US20080255460A1 (en) * | 2007-04-13 | 2008-10-16 | Ethicon Endo-Surgery, Inc. | Nanoparticle tissue based identification and illumination |
WO2009045579A2 (en) * | 2007-06-14 | 2009-04-09 | The Regents Of The University Of California | Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics |
KR100951719B1 (en) * | 2007-10-02 | 2010-04-07 | 재단법인서울대학교산학협력재단 | Complex of Cell Translocational Peptide and Magnetic Nanoparticulates and Use Thereof |
KR101077966B1 (en) * | 2007-11-30 | 2011-10-31 | 고려대학교 산학협력단 | A nanoparticle for separating peptide, method for preparing the same, and method for separating peptide using the same |
FR2928932B1 (en) * | 2008-03-21 | 2010-04-30 | Centre Nat Rech Scient | FLUORESCENT NANOCRYSTALS COATED WITH AN INORGANIC SHELL |
JP5392743B2 (en) * | 2008-05-19 | 2014-01-22 | 独立行政法人理化学研究所 | Water-soluble near-infrared fluorescent material and multimodal water-soluble near-infrared fluorescent material |
US20110105889A1 (en) * | 2008-07-17 | 2011-05-05 | Konica Minolta Medical & Graphic, Inc. | Nanoparticle labeling and system using nanoparticle labeling |
US20110200534A1 (en) * | 2008-08-21 | 2011-08-18 | Industry-Academic Cooperation Foundation, Yonsei U | T1-T2 Dual Modal MRI Contrast Agents |
US8221791B1 (en) * | 2008-12-10 | 2012-07-17 | University Of Central Florida Research Foundation, Inc. | Silica-based antibacterial and antifungal nanoformulation |
EP2424574A2 (en) * | 2009-04-29 | 2012-03-07 | General Electric Company | Nanoparticle contrast agents for diagnostic imaging |
WO2011022350A1 (en) * | 2009-08-17 | 2011-02-24 | Saint Louis Unversity | Zinc nanoparticles for the treatment of infections and cancer |
US8593141B1 (en) | 2009-11-24 | 2013-11-26 | Hypres, Inc. | Magnetic resonance system and method employing a digital squid |
WO2011084625A1 (en) * | 2009-12-16 | 2011-07-14 | Georgia Tech Research Corporation | Systems and methods for x-ray flourescence computed tomography imaging with nanoparticles |
US8970217B1 (en) | 2010-04-14 | 2015-03-03 | Hypres, Inc. | System and method for noise reduction in magnetic resonance imaging |
TW201212942A (en) * | 2010-09-28 | 2012-04-01 | Univ Nat Cheng Kung | CT/MRI dual modality molecular imaging contrast agent and method for manufacturing the same |
US20120083690A1 (en) * | 2010-10-04 | 2012-04-05 | Semenov Serguei Y | System and method for electromagnetic imaging and therapeutics using specialized nanoparticles |
US10286088B2 (en) | 2011-05-05 | 2019-05-14 | Rutgers, The State University Of New Jersey | Multifunctional infrared-emitting composites |
EP2717920A4 (en) | 2011-06-11 | 2015-04-29 | Univ Central Florida Res Found | Activatable nanoprobes for intracellular drug delivery |
US20120323112A1 (en) * | 2011-06-17 | 2012-12-20 | The Board Of Trustees Of The Leland Stanford Junior University | Nanoparticles for accoustic imaging, methods of making, and methods of accoustic imaging |
WO2013033513A1 (en) | 2011-08-31 | 2013-03-07 | University Of Georgia Research Foundation, Inc. | Apoptosis-targeting nanoparticles |
WO2013066630A1 (en) * | 2011-10-18 | 2013-05-10 | The Trustees Of Princeton University | New and greener process to synthesize water-soluble mn2+-doped cdsse(zns) core(shell) nanocrystals for ratiometric temperature sensing, nanocrystals, and methods implementing nanocrystals |
US8993057B2 (en) * | 2011-10-22 | 2015-03-31 | Masoud Salavati-Niasari | Method for preparing silica-dysprosium oxide core-shell nanoparticles |
EP2812344A4 (en) | 2012-02-07 | 2015-10-28 | Vibrant Holdings Llc | Substrates, peptide arrays, and methods |
US10416167B2 (en) | 2012-02-17 | 2019-09-17 | University Of Georgia Research Foundation, Inc. | Nanoparticles for mitochondrial trafficking of agents |
CA2882388C (en) | 2012-08-31 | 2020-10-20 | Sloan-Kettering Institute For Cancer Research | Particles, methods and uses thereof |
EP3611184A1 (en) | 2012-09-19 | 2020-02-19 | Gemvax & Kael Co., Ltd. | Cell penetrating peptide, conjugate comprising the same, and composition comprising conjugate |
KR102544207B1 (en) | 2012-09-19 | 2023-06-16 | 주식회사 젬백스앤카엘 | Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate |
US10006909B2 (en) | 2012-09-28 | 2018-06-26 | Vibrant Holdings, Llc | Methods, systems, and arrays for biomolecular analysis |
KR102166542B1 (en) * | 2012-09-28 | 2020-10-16 | 주식회사 젬백스앤카엘 | Conjugate of telomerase derived peptide and contrast substances for detecting stem cell and Contrast composition comprising the same |
US10286376B2 (en) | 2012-11-14 | 2019-05-14 | Vibrant Holdings, Llc | Substrates, systems, and methods for array synthesis and biomolecular analysis |
CN103045235A (en) * | 2012-12-18 | 2013-04-17 | 上海交通大学 | Method for synthesizing water phase of Mn<2+> doped CdS fluorescent quantum dots by stable acetopyruvic acid |
WO2014100380A2 (en) * | 2012-12-19 | 2014-06-26 | Sloan-Kettering Institute For Cancer Research | Multimodal particles, methods and uses thereof |
JP2016511747A (en) | 2013-01-04 | 2016-04-21 | マサチューセッツ インスティテュート オブ テクノロジー | Drug delivery to tissues based on nanoparticle surface binding |
CA2923379C (en) * | 2013-02-15 | 2023-01-03 | Vibrant Holdings, Llc | Methods and compositions for amplified electrochemiluminescence detection |
EP2958481A4 (en) | 2013-02-20 | 2017-03-08 | Sloan-Kettering Institute for Cancer Research | Wide field raman imaging apparatus and associated methods |
US10912947B2 (en) | 2014-03-04 | 2021-02-09 | Memorial Sloan Kettering Cancer Center | Systems and methods for treatment of disease via application of mechanical force by controlled rotation of nanoparticles inside cells |
WO2015138992A1 (en) | 2014-03-14 | 2015-09-17 | University Of Georgia Research Foundation, Inc. | Mitochondrial delivery of 3-bromopyruvate |
CA2956210A1 (en) | 2014-07-28 | 2016-02-04 | Memorial Sloan Kettering Cancer Center | Metal(loid) chalcogen nanoparticles as universal binders for medical isotopes |
US10578257B2 (en) * | 2014-07-28 | 2020-03-03 | Lumileds Llc | Silica coated quantum dots with improved quantum efficiency |
US9968688B2 (en) | 2014-11-12 | 2018-05-15 | Verily Life Sciences Llc | Shielded targeting agents, methods, and in vivo diagnostic system |
EP3317035A1 (en) | 2015-07-01 | 2018-05-09 | Memorial Sloan Kettering Cancer Center | Anisotropic particles, methods and uses thereof |
CN105079826B (en) * | 2015-09-15 | 2017-12-19 | 广州市第一人民医院 | The preparation and application of a kind of double targeting MR/ optics bimodal molecular probes of RGD@BBN |
JP6776672B2 (en) * | 2016-07-08 | 2020-10-28 | 住友電気工業株式会社 | Quality evaluation method and quality evaluation equipment |
CN106010501B (en) * | 2016-07-25 | 2018-05-01 | 上海交通大学 | Multifunctional nanocomposites of silicon dioxide-coated quantum dots and preparation method thereof |
WO2018067913A1 (en) * | 2016-10-06 | 2018-04-12 | The Penn State Research Foundation | Imaging compositions |
WO2018218250A2 (en) | 2017-05-26 | 2018-11-29 | Vibrant Holdings, Llc | Photoactive compounds and methods for biomolecule detection and sequencing |
ES2702432B2 (en) | 2017-08-31 | 2019-08-05 | Venegas Pedro Manuel Medina | Method and device for nucleic acid analysis |
CN108375563B (en) * | 2018-04-27 | 2020-12-15 | 天津师范大学 | Method for selectively detecting thrombin by phosphorescent probe |
JP2021522963A (en) * | 2018-05-03 | 2021-09-02 | バイオナット ラブス リミテッド | Integrative medicine imaging system for tracking micro / nanoscale objects |
US11428656B2 (en) | 2018-07-05 | 2022-08-30 | AhuraTech LLC | Electroluminescent methods and system for real-time measurements of physical properties |
US11460403B2 (en) | 2018-07-05 | 2022-10-04 | AhuraTech LLC | Electroluminescent methods and devices for characterization of biological specimens |
US11393387B2 (en) | 2018-07-05 | 2022-07-19 | AhuraTech LLC | Open-circuit electroluminescence |
CN108841387A (en) * | 2018-07-18 | 2018-11-20 | 深圳扑浪创新科技有限公司 | A kind of quantum nanoparticles crystalline substance compound and preparation method thereof |
CN110358130B (en) * | 2019-07-26 | 2021-07-09 | 电子科技大学 | Method for improving underwater adhesion capacity of hydrogel, related hydrogel and preparation method thereof |
WO2022031484A1 (en) * | 2020-08-03 | 2022-02-10 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Protected quantum dots for therapeutic, diagnostic, and other uses |
MX2023003106A (en) * | 2020-09-16 | 2023-04-19 | On Target Laboratories Llc | Detection of circulating tumor cells using tumor-targeted nir agents. |
CN113577277B (en) * | 2021-08-03 | 2022-04-08 | 中山大学 | PEOz and polydopamine-gadolinium ion network modified degradable mesoporous silicon nano drug delivery system and preparation method |
CN114507524B (en) * | 2022-01-10 | 2023-10-27 | 东南大学 | Quantum dot fluorescence coding polylactic acid microsphere and preparation method and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001089585A1 (en) * | 2000-05-24 | 2001-11-29 | Biocrystal Ltd. | tLUORESCENT NANOCRYSTAL-LABELLED MICROSPHERES FOR FLUORESCENCE ANALYSES |
WO2004066361A2 (en) * | 2003-01-22 | 2004-08-05 | The Board Of Trustees Of The University Of Arkansas | Monodisperse core/shell and other complex structured nanocrystals and methods of preparing the same |
WO2005041747A2 (en) * | 2003-06-03 | 2005-05-12 | The Trustees Of The University Of Pennsylvania | Stealthy nano agents |
US20050220714A1 (en) * | 2004-04-01 | 2005-10-06 | Susan Kauzlarich | Agents for use in magnetic resonance and optical imaging |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4466896A (en) * | 1983-07-29 | 1984-08-21 | Texaco Inc. | Ethylenediamine triacetic acid siloxane stabilizers for inorganic silicates in antifreeze/coolant formulations |
AU6621586A (en) * | 1985-11-18 | 1987-06-02 | University Of Texas System, The | Polychelating agents for image and spectral enhancement (and spectral shift) |
US5087440A (en) * | 1989-07-31 | 1992-02-11 | Salutar, Inc. | Heterocyclic derivatives of DTPA used for magnetic resonance imaging |
US6322901B1 (en) * | 1997-11-13 | 2001-11-27 | Massachusetts Institute Of Technology | Highly luminescent color-selective nano-crystalline materials |
US6207392B1 (en) * | 1997-11-25 | 2001-03-27 | The Regents Of The University Of California | Semiconductor nanocrystal probes for biological applications and process for making and using such probes |
US5990479A (en) * | 1997-11-25 | 1999-11-23 | Regents Of The University Of California | Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes |
US6699723B1 (en) * | 1997-11-25 | 2004-03-02 | The Regents Of The University Of California | Organo luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes |
US6251303B1 (en) * | 1998-09-18 | 2001-06-26 | Massachusetts Institute Of Technology | Water-soluble fluorescent nanocrystals |
JP2003535063A (en) * | 2000-06-01 | 2003-11-25 | ザ・ボード・オブ・リージェンツ・フォー・オクラホマ・ステート・ユニバーシティー | Bioconjugates of nanoparticles as radiopharmaceuticals |
JP2004509924A (en) * | 2000-09-25 | 2004-04-02 | ザ、プロクター、エンド、ギャンブル、カンパニー | MRI image enhancing composition |
US6649138B2 (en) * | 2000-10-13 | 2003-11-18 | Quantum Dot Corporation | Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media |
ATE556845T1 (en) * | 2001-07-20 | 2012-05-15 | Life Technologies Corp | LUMINESCENT NANOPARTICLES AND THEIR PRODUCTION |
WO2003075765A1 (en) * | 2002-03-05 | 2003-09-18 | Board Of Regents, The University Of Texas System | Biospecific contrast agents |
US20030236457A1 (en) * | 2002-04-24 | 2003-12-25 | Mericle Robert A. | Method of endovascular brain mapping |
US7122384B2 (en) * | 2002-11-06 | 2006-10-17 | E. I. Du Pont De Nemours And Company | Resonant light scattering microparticle methods |
US7846412B2 (en) * | 2003-12-22 | 2010-12-07 | Emory University | Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof |
CN1969190A (en) * | 2004-04-20 | 2007-05-23 | 爱默蕾大学 | Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof |
-
2005
- 2005-05-02 US US10/590,590 patent/US8128908B2/en not_active Expired - Fee Related
- 2005-05-02 WO PCT/US2005/015266 patent/WO2005107818A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001089585A1 (en) * | 2000-05-24 | 2001-11-29 | Biocrystal Ltd. | tLUORESCENT NANOCRYSTAL-LABELLED MICROSPHERES FOR FLUORESCENCE ANALYSES |
WO2004066361A2 (en) * | 2003-01-22 | 2004-08-05 | The Board Of Trustees Of The University Of Arkansas | Monodisperse core/shell and other complex structured nanocrystals and methods of preparing the same |
WO2005041747A2 (en) * | 2003-06-03 | 2005-05-12 | The Trustees Of The University Of Pennsylvania | Stealthy nano agents |
US20050220714A1 (en) * | 2004-04-01 | 2005-10-06 | Susan Kauzlarich | Agents for use in magnetic resonance and optical imaging |
Non-Patent Citations (15)
Title |
---|
AKERMAN M E ET AL: "NANOCRYSTAL TARGETING IN VIVO", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, vol. 99, no. 20, 16 September 2002 (2002-09-16), pages 12617 - 12621, XP001182896, ISSN: 0027-8424 * |
BALLOU B ET AL: "NONINVASIVE IMAGING OF QUANTUM DOTS IN MICE", BIOCONJUGATE CHEMISTRY, vol. 15, no. 1, January 2004 (2004-01-01), pages 79 - 86, XP001047128, ISSN: 1043-1802 * |
CHAN W C W ET AL: "Luminescent quantum dots for multiplexed biological detection and imaging", CURRENT OPINION IN BIOTECHNOLOGY, vol. 13, no. 1, February 2002 (2002-02-01), pages 40 - 46, XP002256995, ISSN: 0958-1669 * |
DUBERTRET B ET AL: "In vivo imaging of quantum dots encapsulated in phospholipid micelles", SCIENCE, vol. 298, no. 5599, 29 November 2002 (2002-11-29), pages 1759 - 1762, XP002255863, ISSN: 0036-8075 * |
GAO X ET AL: "In vivo cancer targeting and imaging with semiconductor quantum dots", NATURE BIOTECHNOLOGY, vol. 22, no. 8, 18 July 2004 (2004-07-18), pages 969 - 976, XP002387133, ISSN: 1087-0156 * |
GAO X ET AL: "Molecular profiling of single cells and tissue specimens with quantum dots", TRENDS IN BIOTECHNOLOGY, vol. 21, no. 9, September 2003 (2003-09-01), pages 371 - 373, XP004450443, ISSN: 0167-7799 * |
HEESUN YANG ET AL: "Water-soluble silica-overcoated CdS:Mn/ZnS semiconductor quantum dots", JOURNAL OF CHEMICAL PHYSICS, vol. 121, no. 15, 15 October 2004 (2004-10-15), pages 7421 - 7426, XP008079941, ISSN: 0021-9606 * |
JAISWAL J K ET AL: "LONG-TERM MULTIPLE COLOR IMAGING OF LIVE CELLS USING QUANTUM DOT BIOCONJUGATES", NATURE BIOTECHNOLOGY, vol. 21, no. 1, January 2003 (2003-01-01), pages 47 - 51, XP009065963, ISSN: 1087-0156 * |
KIM S ET AL: "NEAR-INFRARED FLUORESCENT TYPE II QUANTUM DOTS FOR SENTINEL LYMPH NODE MAPPING", NATURE BIOTECHNOLOGY, vol. 22, no. 1, January 2004 (2004-01-01), pages 93 - 97, XP008053357, ISSN: 1087-0156 * |
LARSON D R ET AL: "WATER-SOLUBLE QUANTUM DOTS FOR MULTIPHOTON FLUORESCENCE IMAGING IN VIVO", SCIENCE, vol. 300, no. 5624, 2003, pages 1434 - 1436, XP008053308, ISSN: 0036-8075 * |
SHARMA ET AL: "Nanoparticles for bioimaging", ADVANCES IN COLLOID AND INTERFACE SCIENCE, vol. 123-126, 17 November 2006 (2006-11-17), pages 471 - 485, XP005848174, ISSN: 0001-8686 * |
TANAKA M: "Photoluminescence properties of Mn<2+>-doped II-VI semiconductor nanocrystals", JOURNAL OF LUMINESCENCE, vol. 100, no. 1-4, December 2002 (2002-12-01), pages 163 - 173, XP004396347, ISSN: 0022-2313 * |
WU X ET AL: "IMMUNOFLUORESCENT LABELING OF CANCER MARKER HER2 AND OTHER CELLULAR TARGETS WITH SEMICONDUCTOR QUANTUM DOTS", NATURE BIOTECHNOLOGY, vol. 21, January 2003 (2003-01-01), pages 41 - 46, XP008053284, ISSN: 1087-0156 * |
YANG H ET AL: "EFFICIENT AND PHOTOSTABLE ZNS-PASSIVATED CDS:MN LUMINESCENT NANOCRYSTALS", ADVANCED FUNCTIONAL MATERIALS, vol. 14, no. 2, February 2004 (2004-02-01), pages 152 - 156, XP001046237, ISSN: 1616-301X * |
YANG HEESUN ET AL: "Enhanced photoluminescence from CdS:Mn/ZnS core/shell quantum dots", APPLIED PHYSICS LETTERS, vol. 82, no. 12, 24 March 2003 (2003-03-24), pages 1965 - 1967, XP012033608, ISSN: 0003-6951 * |
Also Published As
Publication number | Publication date |
---|---|
US8128908B2 (en) | 2012-03-06 |
US20070269382A1 (en) | 2007-11-22 |
WO2005107818A2 (en) | 2005-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005107818A3 (en) | Nanoparticles and their use for multifunctional bioimaging | |
WO2006090389A3 (en) | Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof | |
IL180896A0 (en) | Method of tumour imaging | |
EP2369342A3 (en) | Fluorescent silica-based nanoparticles | |
WO2006102377A3 (en) | Functionalized magnetic nanoparticles and methods of use thereof | |
WO2006133271A3 (en) | Compositions and methods relating to target-specific photodynamic therapy | |
EP2359864A3 (en) | Targeting Vector-Phospholipid Conjugates | |
WO2002081497A3 (en) | αξβ3 INTEGRIN-BINDING POLYPEPTIDE MONOBODIES AND THEIR USE | |
WO2006096754A3 (en) | Stabilized aptamers to psma and their use as prostate cancer therapeutics | |
WO2006004910A3 (en) | Improved bispecific antibodies | |
ZA200610255B (en) | Activable particles, preparations and uses | |
EP2003196A3 (en) | Compositions and methods for treating and diagnosing cancer | |
WO2009043159A8 (en) | Neural tumor stem cells and methods of use thereof | |
WO2008078190A3 (en) | Compounds for fluorescence imaging | |
WO2007047766A3 (en) | Methods for rejuvenating cells in vitro and in vivo | |
EP2687235A3 (en) | Methods for production and use of substance-loaded erythrocytes (S-LES) for observation and treatment of microvascular hemodynamics | |
EP2189541A3 (en) | Methods and reagents for treatment and diagnosis of age-related macular degeneration | |
Al-Kattan et al. | Novel contributions on luminescent apatite-based colloids intended for medical imaging | |
WO2007092343A3 (en) | Novel epoprostenol formulation and method of making thereof | |
DE60223176D1 (en) | METAL COMPLEX COMPOUNDS | |
WO2009012356A3 (en) | Imaging nucleic acid binding proteins | |
EP2324766A3 (en) | Micro-insult test and use therefor | |
WO2014181960A3 (en) | Fluorescent probe sensing tyrosine kinase and use thereof | |
ATE309254T1 (en) | TISSUE-SPECIFIC FLUORESCENT CHELATES | |
EP2527427A3 (en) | Multipotent postnatal stem cells from human periodontal ligament and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10590590 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase | ||
WWP | Wipo information: published in national office |
Ref document number: 10590590 Country of ref document: US |